🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Aalborg
Clinical trial register · Denmark

Clinical Trials in Aalborg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2473 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
2473
Studies in scope
all four open statuses
1402
Recruiting now
open to new participants
436
Lead sponsors
across recruiting studies
Top sites
Copenhagen 971 Aarhus 588 Odense 439 Aalborg 382 Herlev 309
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Aalborg University Hospital35 University of Aarhus22 AstraZeneca22 Merck Sharp & Dohme LLC17 Aalborg University16
Site location
Copenhagen971 Aarhus588 Odense439 Aalborg382 Herlev309
All 128 locations
Target enrolment
to

Trials with a site in Aalborg

382 of 2473 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Active, closed
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236Platinum-resistant Ovarian Cancer
DrugsRina-S·Pegylated liposomal doxorubicin·Topotecan·Gemcitabine
Genmab
Phase 3
530
Aalborg, Copenhagen, Odense
2025-02-07
Recruiting
The Ventilation During In-hospital Cardiac Arrest Study
NCT06809309Cardiac Arrest (CA), In-Hospital Cardiac Arrest, Heart Arrest
University of Aarhus
Observational
900
Aabenraa, Aalborg, Aarhus, Esbjerg, Gødstrup, Hjørring, Horsens, Odense
2025-02-01
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Aalborg, Aarhus N, Copenhagen, Odense C
2025-01-30
Recruiting
The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
NCT06790082Pleural Mesothelioma, Pleural Diseases, Cancer, FAPI
Drug[68Ga]Ga-FAPI-46 PET/CT
Aalborg University Hospital
Phase 2
70
Aalborg
2025-01-29
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
NCT06717347Diffuse Large B-Cell Lymphoma
DrugsRituximab Biosimilar·Zilovertamab vedotin·Prednisolone·Methylprednisolone
Merck Sharp & Dohme LLC
Phase 3
1,046
Aarhus, Herning, Aalborg, Odense
2025-01-27
Recruiting
Newborn Jaundice - An Investigation of Different Approaches to Light Therapy
NCT06702241Neonatal Hyperbilirubinemia
Regionshospital Nordjylland
Phase 2/3
116
Aalborg, Hjørring
2025-01-14
Recruiting
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
NCT06709196Cystectomy, Bladder Cancer Requiring Cystectomy, Postoperative Infections, Antibiotic Prophylaxis
DrugsAmoxicillin clavulanic acid·Cefuroxime·Pivmecillinam·Nitrofurantoin
Rigshospitalet, Denmark
Phase 4
248
Aalborg, Aarhus, Copenhagen, Herlev, Odense
2025-01-07
Recruiting
Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
NCT06503510Itch
Aalborg University
Not applicable
20
Gistrup, Aalborg
2025-01-06
Recruiting
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
NCT06227910Crohn's Disease
DrugsVedolizumab·Upadacitinib
Takeda
Phase 3
396
Aalborg, Hvidovre
2025-01-02
Not yet open
More Steps Towards an Active Life After Stroke - ActForStroke
NCT06715566Stroke Not Otherwise Specified
University of Aarhus
Not applicable
50
Aalborg, Brønderslev, Copenhagen, Hammel, Jammerbugt, Skive, Svendborg, Thisted
2025-01-01
Recruiting
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
NCT06557798Aortic Valve Stenosis
The Leeds Teaching Hospitals NHS Trust
Observational
550
Aalborg, Aarhus, Copenhagen
2024-12-12
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06588855Moderately to Severely Active Ulcerative Colitis
DrugAfimkibart
Hoffmann-La Roche
Phase 3
350
Aalborg
2024-12-11
Active, closed
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
NCT06534983Muscle-invasive Urothelial Carcinoma
DrugsAutogene cevumeran·Nivolumab
Hoffmann-La Roche
Phase 2
62
Aalborg, Aarhus N, Herlev
2024-12-09
Recruiting
Drainage Of Pleural Effusions in the Intensive Care Unit (DOPE-ICU) - Feasibility Trial
NCT06709456Pleural Effusions, Respiratory Failure
Olav Schjørring
Not applicable
88
Aalborg, Copenhagen, Hillerød, Kolding, Køge, Roskilde
2024-12-02
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Aalborg, Copenhagen, Vejle
2024-11-27
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
NCT06617325Systemic Lupus Erythematosus
UCB Biopharma SRL
Phase 3
450
Aalborg, Aarhus, Copenhagen, Odense
2024-11-21
Recruiting
Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention
NCT06692140Ischemia, Myocardial, Coronary Artery Disease, Percutaneous Coronary Intervention (PCI)
Odense University Hospital
Not applicable
3,150
Aalborg, Aarhus, Odense
2024-11-16
Recruiting
Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents
NCT06718179Acute Coronary Syndrome
Odense University Hospital
Phase 4
3,150
Aalborg, Aarhus, Odense
2024-11-16
By invitation
Skeletal Maturation and Endocrine Health in Young Adults
NCT06509776Osteoporosis, Sarcopenia, Obesity, Cardiovascular Diseases
Holbaek Sygehus
Observational
2,000
Aalborg, Aarhus, Copenhagen, Frederiksberg, Holbæk, Hvidovre, Køge, Odense
2024-11-11
Recruiting
Itch Sensation Induced by Multiple Applications of Pruritogens (temporal Summation)
NCT06328543Histamine, Cowhage
Aalborg University
Not applicable
26
Aalborg
2024-11-01
Active, closed
Tonsillectomy Versus Tonsillotomy in the Treatment of Recurrent Acute Tonsillitis
NCT06606262Tonsillitis Recurrent
Tejs Ehlers Klug
Not applicable
250
Aalborg, Aarhus
2024-10-31
Recruiting
Efficacy of a Home-based Stretching Program on Fibromyalgia Symptoms: a Randomised Controlled Trial
NCT06487741Fibromyalgia, Stretch, Adherence, Treatment
University College of Northern Denmark
Not applicable
58
Aalborg
2024-10-31
Recruiting
Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing
NCT06210555Kidney Transplantation, Multiparametric Magnetic Resonance Imaging, Living Donors, Renal Fibrosis
Patrick Schjelderup
Observational
96
Aarhus, Aalborg
2024-10-29
Active, closed
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
NCT06643481Amyotrophic Lateral Sclerosis (ALS)
DrugVHB937
Novartis Pharmaceuticals
Phase 2
251
Aalborg, Kobenhavn N V
2024-10-17
Active, closed
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
NCT06473779Severe Asthma
AstraZeneca
Phase 3
326
Aalborg, Hvidovre, Svendborg, Vejle
2024-09-30
Recruiting
Development of Computational Models to Predict the Short-, Medium- and Long-term Cartilage Degeneration and Pain for Patients With Early-stage Osteoarthritis or Anterior Cruciate Ligament Injury
NCT07134244Osteoarthritis, Knee, Anterior Cruciate Ligament Injuries
Aalborg University
Observational
105
Aalborg
2024-09-26
Recruiting
Understanding and Tailored Treatment of Low Anterior Resection Syndrome
NCT07573371Low Anterior Resection Syndrome, Faecal Incontinence With Faecal Urgency, Faecal Incontinence, Colorectal (Colon or Rectal) Cancer Survivors
Aalborg University Hospital
Observational
145
Aalborg, Aarhus, Vejle
2024-09-17
Recruiting
RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
NCT06614647Colorectal Cancer, Quality of Life, Survivorship
University of Aarhus
Not applicable
400
Herning, Randers, Aalborg, Odense, Svendborg, Aarhus, Copenhagen, Horsens
2024-09-15
Active, closed
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142Immunoglobulin A Nephropathy
DrugPovetacicept
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Aalborg, Copenhagen, Hillerød, Kolding
2024-08-30
Active, closed
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824Kidney Disease, Chronic
DrugsVicadrostat·Dapagliflozin
Boehringer Ingelheim
Phase 3
11,000
Aalborg, Copenhagen, Herlev, Kolding, Odense, Roskilde
2024-08-30
Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06452277Advanced Non-small Cell Lung Cancer, HER2 Mutation
DrugsSevabertinib·Pemetrexed·Cisplatin·Carboplatin
Bayer
Phase 3
555
Copenhagen, Aarhus N, Herning, Aalborg, Odense
2024-08-28
Recruiting
Danish Evaluation of Early Catheter Ablation for Atrial Fibrillation in Patients With Heart Failure
NCT06560047Atrial Fibrillation, Heart Failure
Aalborg University Hospital
Not applicable
1,616
Aalborg, Aarhus, Copenhagen, Hellerup, Odense, Roskilde
2024-08-28
Active, closed
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
NCT06564311Relapsing Multiple Sclerosis
DrugObexelimab
Zenas BioPharma (USA), LLC
Phase 2
93
Aalborg
2024-08-26
Recruiting
Clinical Prediction of Post-surgical Pain
NCT06661642Acute Postoperative Pain, Chronic Post Operative Pain
Aarhus University Hospital
Observational
748
Aalborg, Copenhagen
2024-08-26
By invitation
Frailty Outcomes And Risk With Alzheimer's Related Dementia
NCT06570109Alzheimer Disease
Aalborg University Hospital
Observational
130
Aalborg
2024-08-22
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
NCT06549595Untreated Follicular Lymphoma
DrugsSurovatamig·R-Chop
AstraZeneca
Phase 3
1,018
Aalborg, Copenhagen, Odense C, Roskilde
2024-08-07
Active, closed
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
NCT06440967Hot Flashes
DrugsFezolinetant·Tamoxifen
Astellas Pharma Global Development, Inc.
Phase 3
982
Aalborg, Esbjerg, Hillerød, Næstved, Sønderborg
2024-07-31
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
NCT06252649Metastatic Colorectal Cancer
DrugsBevacizumab-awwb·Mvasi·Lumakras·Sotorasib
Amgen
Phase 3
450
Aalborg, Aarhus N, Copenhagen, Odense C
2024-07-17
Recruiting
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
NCT06551246Urinary Incontinence in Children
DrugsSolifenacin·Mirabegron
University of Aarhus
Phase 3
236
Aalborg, Aarhus, Esbjerg, Herning, Kolding
2024-06-27
Active, closed
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
NCT06118281Cardiovascular Risk, Acute Myocardial Infarction (AMI)
DrugZiltivekimab
Novo Nordisk A/S
Phase 3
10,000
Hellerup, Aalborg, Aarhus N, Gistrup, Hillerød, København Ø, Odense C, Svendborg
2024-06-25
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
NCT06393374Triple-Negative Breast Cancer
DrugsSacituzumab tirumotecan·Capecitabine·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
1,530
Herlev, Aarhus N, Aalborg, Odense C, Sønderborg, Vejle
2024-06-24
Recruiting
Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
NCT06474806Prostate Cancer
Curasight
Phase 2
168
Herlev, Vejle, Aalborg
2024-06-01
Recruiting
The NONA-LISA Trial
NCT05609877Respiratory Distress Syndrome in Premature Infant
DrugFentanyl
Rigshospitalet, Denmark
Not applicable
324
Aalborg, Aarhus, Copenhagen, Odense
2024-06-01
Active, closed
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)
NCT06465576Urinary Incontinence in Children
DrugsSolifenacin·Mirabegron
University of Aarhus
Phase 4
216
Aalborg, Aarhus, Esbjerg, Herning, Kolding
2024-05-27
Recruiting
Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect
NCT06396260Amyotrophic Lateral Sclerosis, Pseudobulbar Affect
Aalborg University Hospital
Not applicable
50
Aalborg
2024-05-26
Active, closed
Tocilizumab for Painful Chronic Pancreatitis
NCT06426160Pancreatitis, Chronic
DrugsSodium Chloride Inj·Tocilizumab
Soren Schou Olesen
Phase 2
32
Aalborg
2024-05-21
Recruiting
Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
NCT06401616Atrial Fibrillation, Left Atrial Appendage Absent, Anticoagulant Adverse Reaction
Odense University Hospital
Phase 4
1,220
Copenhagen, Gentofte Municipality, Herning, Aalborg, Aarhus, Odense
2024-05-21
Recruiting
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
NCT06353386Prostatic Neoplasms, Castration-Resistant
DrugsFludrocortisone acetate·Opevesostat·Cabazitaxel·Olaparib
Merck Sharp & Dohme LLC
Phase 1/2
220
Copenhagen, Aalborg
2024-05-20
Active, closed
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
NCT06407934Dermatitis Atopic
DrugAmlitelimab
Sanofi
Phase 3
1,541
Aalborg, Aarhus, Herlev
2024-05-08
Active, closed
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
NCT06356311Gastroesophageal Cancer
DrugsTrifluridine/Tipiracil·Sacituzumab tirumotecan·Irinotecan·Docetaxel
Merck Sharp & Dohme LLC
Phase 3
450
Copenhagen, Aalborg, Odense
2024-05-03
Active, closed
Incidence of Macular Edema in a Uveitis Population
NCT06686641Macular Edema, Non-infectious Uveitis
Aalborg University Hospital
Observational
1,550
Aalborg
2024-05-01
Recruiting
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
NCT06338995Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
DrugLebrikizumab
Eli Lilly and Company
Phase 3
510
Aalborg, Aarhus, Copenhagen, Køge
2024-04-29
Recruiting
Investigate the Relationship Between Catastrophizing and the Perception of Itch Intensity in Healthy Individuals
NCT06340438Histamine, Cowhage
Aalborg University
Not applicable
46
Aalborg
2024-04-27
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961End Stage Kidney Disease
DrugClazakizumab
CSL Behring
Phase 2/3
3,110
Aalborg, Herlev, Herning, Hillerød, Holbæk
2024-04-27
Recruiting
Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease
NCT06356779Oligometastatic Disease, Metastases, Ablation Techniques, Radiotherapy
Gitte Fredberg Persson MD PhD
Not applicable
1,200
Copenhagen, Herlev, Hillerød, Aarhus, Herning, Aalborg, Roskilde, Odense
2024-04-15
Recruiting
Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density
NCT06367725Acute Lymphoblastic Leukemia
University of Aarhus
Observational
100
Aalborg, Aarhus N, Copenhagen, Odense
2024-04-11
Recruiting
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL
NCT05791409CLL/SLL
DrugsEpcoritamab·Venetoclax
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
Aalborg, Copenhagen, Odense
2024-04-10
Recruiting
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
NCT06274515Breast Cancer
Hoffmann-La Roche
Phase 4
320
Aalborg, Næstved
2024-04-02
Recruiting
Itch Sensation Induced by Simultaneous Application of Pruritogens (Spatial Summation)
NCT06328530Histamine, Cowhage
Aalborg University
Not applicable
24
Aalborg
2024-04-01
Recruiting
Exploring Multimorbidity in Patients With Spinal Pain
NCT06402409Back Pain, Neck Pain, Comorbidities and Coexisting Conditions
Jacob Christiansen Gandløse
Observational
2,000
Aalborg
2024-04-01
Not yet open
Fracture Pattern Following Bilateral Sagittal Split Osteotomy With or Without Impacted Third Molars
NCT06338982Impacted Third Molar Tooth, Osteotomy, Orthognathic Surgery, Mandibular Fractures
Kimie Bols Østergaard
Not applicable
150
Aalborg
2024-03-30
Active, closed
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
NCT06254950Ulcerative Colitis
DrugZasocitinib
Takeda
Phase 2
213
Odense, Aalborg, Esbjerg, Hillerød, Hvidovre, Køge
2024-03-29
Active, closed
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
NCT06268873Chronic Kidney Disease and Hypertension
DrugBaxdrostat/dapagliflozin
AstraZeneca
Phase 3
2,554
Aalborg, Aarhus, Copenhagen E, Esbjerg, Herlev, Herning, Holbæk
2024-03-29
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
NCT06072781Low Grade Serous Ovarian Cancer
DrugsDefactinib·Avutometinib·Pegylated liposomal doxorubicin·Anastrozole
Verastem, Inc.
Phase 3
270
Aalborg
2024-03-18
Active, closed
VIsualization of Coronary Artery Disease for Modification of RISK Factors
NCT06413641Coronary Artery Disease, Non-Obstructive Coronary Atherosclerosis
Aarhus University Hospital
Not applicable
273
Gødstrup, Aalborg, Aarhus, Esbjerg, Vejle
2024-03-12
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966COPD (Chronic Obstructive Pulmonary Disease)
AstraZeneca
Phase 3
5,000
Aalborg, Esbjerg, Hvidovre, København NV, Næstved, Vejle
2024-02-21
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
NCT06152575Multiple Myeloma
DrugsElotuzumab·Elranatamab·Carfilzomib·Pomalidomide
Pfizer
Phase 3
492
Aarhus, Aalborg, Copenhagen Ø
2024-02-08
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
NCT06072482Antineutrophil Cytoplasmic Antibody-associated Vasculitis
DrugAvacopan
Amgen
Phase 4
300
Aalborg, Copenhagen, Odense C
2024-02-07
Recruiting
The Pro-Chol Study
NCT07245108Gallstones, Gallstone Attack, Uncomplicated Cholelithiasis, Cholecystolithiasis
Nordsjaellands Hospital
Observational
800
Copenhagen, Aalborg, Herlev, Hillerød, Hjørring, Hvidovre, Viborg
2024-01-22
Recruiting
Strategy for Prompt and Effective Thoracentesis in the Emergency Department
NCT06180603Pleural Effusion, Pleural Diseases, Heart Failure
University of Aarhus
Not applicable
188
Aarhus, Gødstrup, Horsens, Randers, Aalborg, Esbjerg
2024-01-15
Active, closed
TeleCare North Diabetes
NCT06134934Diabetes Mellitus, Type 2
Aalborg University Hospital
Not applicable
60
Aalborg
2024-01-09
Recruiting
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
NCT06285318Relapsed/Refractory Multiple Myeloma (RRMM)
Janssen-Cilag Ltd.
Observational
900
Aalborg, Aarhus N, Copenhagen, Odense, Vejle
2023-12-18
Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
NCT06170788Non-small Cell Lung Cancer (NSCLC)
DrugsSacituzumab tirumotecan·Keytruda·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
614
Herning, Aalborg, Odense C
2023-12-15
Recruiting
Investigation of the Effects of Sleep Fragmentation on Itch and Pain Sensitivity
NCT06081946Histamine, Cowhage, Sleep Fragmentation
Aalborg University
Not applicable
30
Aalborg
2023-12-15
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
NCT06136559Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsNemtabrutinib·Ibrutinib·Acalabrutinib
Merck Sharp & Dohme LLC
Phase 3
1,200
Aalborg, Roskilde, Odense C
2023-12-13
Active, closed
U011 - Wireless Ultra Long-Term EEG Recordings in Epilepsy
NCT05915988Epilepsy
UNEEG Medical A/S
Not applicable
19
Aalborg, Odense, Viborg
2023-12-04
Active, closed
Deprescribing dRrugs for Overactive Bladder in General Practice (DROP)
NCT06110975Overactive Bladder, Deprescribing, PIMS
Anne Estrup Olesen
Not applicable
72
Aalborg
2023-12-01
Recruiting
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
NCT05890729Pulmonary Sarcoidosis
Xentria, Inc.
Phase 1/2
94
Aalborg, Aarhus, Odense, Roskilde, Vejle
2023-11-10
Recruiting
Exploration of Gait Biomechanics and Muscle Pain of the Lower Extremity
NCT06411197Pain, Acute
Kristian Kjær Petersen
Not applicable
36
Aalborg
2023-11-08
Active, closed
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
NCT06087835Chronic Kidney Disease With High Proteinuria
DrugDapagliflozin
AstraZeneca
Phase 3
1,835
Aalborg, Aarhus, Herlev, Herning, Roskilde
2023-11-07
Recruiting
Proton Cranio-spinal Irradiation for Leptomeningeal Metastasis
NCT05746754Leptomeningeal Metastasis
University of Aarhus
Not applicable
50
Aarhus, Aalborg
2023-11-01
Recruiting
Long-term Home-based Exercise for Patients With COPD: the COPDtoParis Project
NCT06235502Telerehabilitation, COPD, Quality of Life, Mobility Limitation
Aalborg University Hospital
Not applicable
40
Aalborg
2023-11-01
Recruiting
Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity
NCT06081998Histamine, Cowhage, Sleep Deprivation
Aalborg University
Not applicable
30
Aalborg
2023-11-01
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Aalborg, Aarhus N, Herlev, Hillerød, Næstved, Sønderborg
2023-10-24
Recruiting
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
NCT05546138Neuropathy, Diabetic, Small Nerve Fiber Neuropathy, Type 1 Diabetes
Aalborg University Hospital
Observational
200
Aalborg
2023-10-01
Active, closed
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
NCT06047080Large B-Cell Lymphoma
DrugsPolatuzumab Vedotin·Glofitamab·Doxorubicin·Prednisone
Hoffmann-La Roche
Phase 3
1,130
Aalborg, Aarhus N, Herning
2023-09-18
Active, closed
Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
NCT05846230Bronchiectasis
DrugVerducatib
Boehringer Ingelheim
Phase 2
268
Aalborg, Hvidovre, København Ø, Odense, Roskilde, Vejle
2023-09-08
Active, closed
Is Casting of Displaced Pediatric Distal Forearm Fractures Non-inferior to Reduction in General Anesthesia?
NCT05736068Distal Forearm Fracture, Distal Radius Fracture
Zealand University Hospital
Not applicable
40
Aalborg, Aarhus, Køge, Odense
2023-09-07
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
DrugsCyclophosphamid·Rituximab
Alentis Therapeutics AG
Phase 2
80
Aalborg, Aarhus, Copenhagen, Herlev, Odense
2023-09-07
Recruiting
Danish Angle Closure Prevention Trial
NCT06077253Primary Angle Glaucoma Closure Suspect
University of Aarhus
Not applicable
242
Aalborg, Aarhus, Glostrup Municipality, Odense, Vejle
2023-09-01
Not yet open
Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty
NCT05957991Puberty, Precocious
DrugMetformin
Copenhagen University Hospital at Herlev
Observational
1,500
Herlev, Aalborg, Aarhus, Odense, Roskilde
2023-09-01
Not yet open
The Effect of Adding Auditory Information on Head Movements in People With Non-traumatic Neck Pain
NCT06028269Healthy, Neck Pain
Aalborg University
Not applicable
44
Aalborg, Gistrup
2023-08-31
Not yet open
The Effect of Adding Auditory Information on Head Movements in People With Traumatic Neck Pain
NCT06028308Whiplash, Healthy
Aalborg University
Not applicable
44
Aalborg, Gistrup
2023-08-31
Active, closed
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267Asthma
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,772
Aalborg, Hvidovre, Vejle
2023-08-30
Recruiting
Perioperative Treatment With Tranexamic Acid in Melanoma
NCT05899465Melanoma
DrugTranexamic Acid
University of Aarhus
Phase 3
1,204
Aarhus, Aalborg, Copenhagen, Herlev, Vejle
2023-08-25
Recruiting
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
NCT05947669Colitis
DrugsInfliximab·Prednisolone·Methylprednisolone
Odense University Hospital
Phase 3
195
Aalborg, Odense
2023-08-22
Recruiting
DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
NCT06076811Colorectal Neoplasms, Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Stage I
University of Aarhus
Observational
1,600
Copenhagen, Herlev, Aarhus, Herning, Horsens, Randers, Viborg, Aalborg
2023-08-01
Recruiting
GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
NCT06111105Colorectal Cancer Stage III, Liver Metastasis Colon Cancer
Claus Lindbjerg Andersen
Observational
590
Copenhagen, Herlev, Aarhus, Herning, Horsens, Randers, Viborg, Aalborg
2023-08-01
Recruiting
Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
NCT05889247Non-small Cell Lung Cancer Metastatic
Zealand University Hospital
Not applicable
350
Hillerød, Næstved, Roskilde, Aalborg, Vejle
2023-07-28
Active, closed
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
NCT05933577Melanoma
DrugsIntismeran autogene·Keytruda·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
1,089
Copenhagen, Aalborg, Odense C
2023-07-19
Rows per page Showing 101–200 of 382
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-denmark/city/aalborg?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,473 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 382 of those studies with a site in Aalborg.

How many clinical trials are recruiting in Aalborg?

206 of the 382 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 23 have not yet opened recruitment, 142 are active but closed to new participants, and 11 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.